This page is part of the FHIR Specification (v4.0.1: R4 - Mixed Normative and STU) in it's permanent home (it will always be available at this URL). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3 R2
Vocabulary Work Group | Maturity Level: N/A | Standards Status: Informative |
Raw XML (canonical form + also see XML Format Specification)
The manufacturer of a vaccine.
<?xml version="1.0" encoding="UTF-8"?> <ValueSet xmlns="http://hl7.org/fhir"> <id value="v3-VaccineManufacturer"/> <meta> <lastUpdated value="2018-08-12T00:00:00.000+10:00"/> <profile value="http://hl7.org/fhir/StructureDefinition/shareablevalueset"/> </meta> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p> Release Date: 2018-08-12</p> <table class="grid"> <tr> <td> <b> Level</b> </td> <td> <b> Code</b> </td> <td> <b> Display</b> </td> <td> <b> Definition</b> </td> </tr> <tr> <td> 1</td> <td> AB <a name="v3-VaccineManufacturer-AB"> </a> </td> <td> Abbott Laboratories (includes Ross Products Division)</td> <td> Abbott Laboratories (includes Ross Products Division) <br/> </td> </tr> <tr> <td> 1</td> <td> AD <a name="v3-VaccineManufacturer-AD"> </a> </td> <td> Adams Laboratories</td> <td> Adams Laboratories <br/> </td> </tr> <tr> <td> 1</td> <td> ALP <a name="v3-VaccineManufacturer-ALP"> </a> </td> <td> Alpha Therapeutic Corporation</td> <td> Alpha Therapeutic Corporation <br/> </td> </tr> <tr> <td> 1</td> <td> AR <a name="v3-VaccineManufacturer-AR"> </a> </td> <td> Armour [Inactive - use CEN]</td> <td> Armour [Inactive-use CEN] <br/> </td> </tr> <tr> <td> 1</td> <td> AVI <a name="v3-VaccineManufacturer-AVI"> </a> </td> <td> Aviron</td> <td> Aviron <br/> </td> </tr> <tr> <td> 1</td> <td> BA <a name="v3-VaccineManufacturer-BA"> </a> </td> <td> Baxter Healthcare Corporation</td> <td> Baxter Healthcare Corporation <br/> </td> </tr> <tr> <td> 1</td> <td> BAY <a name="v3-VaccineManufacturer-BAY"> </a> </td> <td> Bayer Corporation (includes Miles, Inc. and Cutter Laboratories)</td> <td> Bayer Corporation (includes Miles, Inc. and Cutter Laboratories) <br/> </td> </tr> <tr> <td> 1</td> <td> BP <a name="v3-VaccineManufacturer-BP"> </a> </td> <td> Berna Products [Inactive - use BPC]</td> <td> Berna Products [Inactive-use BPC] <br/> </td> </tr> <tr> <td> 1</td> <td> BPC <a name="v3-VaccineManufacturer-BPC"> </a> </td> <td> Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne)</td> <td> Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne) <br/> </td> </tr> <tr> <td> 1</td> <td> CEN <a name="v3-VaccineManufacturer-CEN"> </a> </td> <td> Centeon L.L.C. (includes Armour Pharmaceutical Company)</td> <td> Centeon L.L.C. (includes Armour Pharmaceutical Company) <br/> </td> </tr> <tr> <td> 1</td> <td> CHI <a name="v3-VaccineManufacturer-CHI"> </a> </td> <td> Chiron Corporation</td> <td> Chiron Corporation <br/> </td> </tr> <tr> <td> 1</td> <td> CON <a name="v3-VaccineManufacturer-CON"> </a> </td> <td> Connaught [Inactive - use PMC]</td> <td> Connaught [Inactive-use PMC] <br/> </td> </tr> <tr> <td> 1</td> <td> EVN <a name="v3-VaccineManufacturer-EVN"> </a> </td> <td> Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.)</td> <td> Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.) <br/> </td> </tr> <tr> <td> 1</td> <td> GRE <a name="v3-VaccineManufacturer-GRE"> </a> </td> <td> Greer Laboratories, Inc.</td> <td> Greer Laboratories, Inc. <br/> </td> </tr> <tr> <td> 1</td> <td> IAG <a name="v3-VaccineManufacturer-IAG"> </a> </td> <td> Immuno International AG</td> <td> Immuno International AG <br/> </td> </tr> <tr> <td> 1</td> <td> IM <a name="v3-VaccineManufacturer-IM"> </a> </td> <td> Merieux [Inactive - use PMC]</td> <td> Merieux [Inactive-use PMC] <br/> </td> </tr> <tr> <td> 1</td> <td> IUS <a name="v3-VaccineManufacturer-IUS"> </a> </td> <td> Immuno-U.S., Inc.</td> <td> Immuno-U.S., Inc. <br/> </td> </tr> <tr> <td> 1</td> <td> JPN <a name="v3-VaccineManufacturer-JPN"> </a> </td> <td> The Research Foundation for Microbial Diseases of Osaka University (BIKEN)</td> <td> The Research Foundation for Microbial Diseases of Osaka University (BIKEN) <br/> </td> </tr> <tr> <td> 1</td> <td> KGC <a name="v3-VaccineManufacturer-KGC"> </a> </td> <td> Korea Green Cross Corporation</td> <td> Korea Green Cross Corporation <br/> </td> </tr> <tr> <td> 1</td> <td> LED <a name="v3-VaccineManufacturer-LED"> </a> </td> <td> Lederle [Inactive - use WAL]</td> <td> Lederle [Inactive-use WAL] <br/> </td> </tr> <tr> <td> 1</td> <td> MA <a name="v3-VaccineManufacturer-MA"> </a> </td> <td> Massachusetts Public Health Biologic Laboratories</td> <td> Massachusetts Public Health Biologic Laboratories <br/> </td> </tr> <tr> <td> 1</td> <td> MED <a name="v3-VaccineManufacturer-MED"> </a> </td> <td> MedImmune, Inc.</td> <td> MedImmune, Inc. <br/> </td> </tr> <tr> <td> 1</td> <td> MIL <a name="v3-VaccineManufacturer-MIL"> </a> </td> <td> Miles [Inactive - use BAY]</td> <td> Miles [Inactive-use BAY] <br/> </td> </tr> <tr> <td> 1</td> <td> MIP <a name="v3-VaccineManufacturer-MIP"> </a> </td> <td> Bioport Corporation (formerly Michigan Biologic Products Institute)</td> <td> Bioport Corporation (formerly Michigan Biologic Products Institute) <br/> </td> </tr> <tr> <td> 1</td> <td> MSD <a name="v3-VaccineManufacturer-MSD"> </a> </td> <td> Merck and Co., Inc.</td> <td> Merck & Co., Inc. <br/> </td> </tr> <tr> <td> 1</td> <td> NAB <a name="v3-VaccineManufacturer-NAB"> </a> </td> <td> NABI (formerly North American Biologicals, Inc.)</td> <td> NABI (formerly North American Biologicals, Inc.) <br/> </td> </tr> <tr> <td> 1</td> <td> NAV <a name="v3-VaccineManufacturer-NAV"> </a> </td> <td> North American Vaccine, Inc.</td> <td> North American Vaccine, Inc. <br/> </td> </tr> <tr> <td> 1</td> <td> NOV <a name="v3-VaccineManufacturer-NOV"> </a> </td> <td> Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited)</td> <td> Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited) <br/> </td> </tr> <tr> <td> 1</td> <td> NYB <a name="v3-VaccineManufacturer-NYB"> </a> </td> <td> New York Blood Center</td> <td> New York Blood Center <br/> </td> </tr> <tr> <td> 1</td> <td> ORT <a name="v3-VaccineManufacturer-ORT"> </a> </td> <td> Ortho Diagnostic Systems, Inc.</td> <td> Ortho Diagnostic Systems, Inc. <br/> </td> </tr> <tr> <td> 1</td> <td> OTC <a name="v3-VaccineManufacturer-OTC"> </a> </td> <td> Organon Teknika Corporation</td> <td> Organon Teknika Corporation <br/> </td> </tr> <tr> <td> 1</td> <td> PD <a name="v3-VaccineManufacturer-PD"> </a> </td> <td> Parkedale Pharmaceuticals (formerly Parke-Davis)</td> <td> Parkedale Pharmaceuticals (formerly Parke-Davis) <br/> </td> </tr> <tr> <td> 1</td> <td> PMC <a name="v3-VaccineManufacturer-PMC"> </a> </td> <td> Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux)</td> <td> Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) <br/> </td> </tr> <tr> <td> 1</td> <td> PRX <a name="v3-VaccineManufacturer-PRX"> </a> </td> <td> Praxis Biologics [Inactive - use WAL]</td> <td> Praxis Biologics [Inactive-use WAL] <br/> </td> </tr> <tr> <td> 1</td> <td> SCL <a name="v3-VaccineManufacturer-SCL"> </a> </td> <td> Sclavo, Inc.</td> <td> Sclavo, Inc. <br/> </td> </tr> <tr> <td> 1</td> <td> SI <a name="v3-VaccineManufacturer-SI"> </a> </td> <td> Swiss Serum and Vaccine Inst. [Inactive - use BPC]</td> <td> Swiss Serum and Vaccine Inst. [Inactive-use BPC] <br/> </td> </tr> <tr> <td> 1</td> <td> SKB <a name="v3-VaccineManufacturer-SKB"> </a> </td> <td> SmithKline Beecham</td> <td> SmithKline Beecham <br/> </td> </tr> <tr> <td> 1</td> <td> USA <a name="v3-VaccineManufacturer-USA"> </a> </td> <td> United States Army Medical Research and Materiel Command</td> <td> United States Army Medical Research and Materiel Command <br/> </td> </tr> <tr> <td> 1</td> <td> WA <a name="v3-VaccineManufacturer-WA"> </a> </td> <td> Wyeth-Ayerst [Inactive - use WAL]</td> <td> Wyeth-Ayerst [Inactive-use WAL] <br/> </td> </tr> <tr> <td> 1</td> <td> WAL <a name="v3-VaccineManufacturer-WAL"> </a> </td> <td> Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics)</td> <td> Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics) <br/> </td> </tr> </table> </div> </text> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status"> <valueCode value="external"/> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"> <valueInteger value="0"/> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"> <valueCode value="vocab"/> </extension> <url value="http://terminology.hl7.org/ValueSet/v3-VaccineManufacturer"/> <identifier> <system value="urn:ietf:rfc:3986"/> <value value="urn:oid:2.16.840.1.113883.1.11.227"/> </identifier> <version value="2018-08-12"/> <name value="v3.VaccineManufacturer"/> <title value="v3 Code System VaccineManufacturer"/> <status value="active"/> <experimental value="false"/> <date value="2018-08-12"/> <publisher value="HL7, Inc"/> <contact> <telecom> <system value="url"/> <value value="http://hl7.org"/> </telecom> </contact> <description value=" The manufacturer of a vaccine."/> <immutable value="true"/> <compose> <include> <system value="http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer"/> </include> </compose> </ValueSet>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.